Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02983799
Title Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications

ovarian endometrial cancer

ovarian serous carcinoma

Therapies

Olaparib

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.